The Role of Natural Products in the Discovery of New Drug Candidates for the Treatment of Neurodegenerative Disorders II: Alzheimers Disease
Abstract
The present review is part II in a series (part I focuses on Parkinson's Disease) that addresses the value of natural product chemistry in the discovery of medicines for the treatment of neurodegenerative disorders. Data reviewed document that a host of products from plant species and derivatives have neuroprotectant effects in vitro and in vivo. In addition, besides neuroprotection, natural products also demonstrate biological effects that target biochemical pathways underlying associated symptoms of neurdegnerative disorders that include cognitive impairments, energy/fatigue, mood, and anxiety. This part of the review series focuses specifically upon Alzheimer's Disease (AD). AD is postulated to result from extracellular formation of amyloid plaques and intracellular deposits of neurofibrilary tangles in the hippocampus, cerebral cortex and other areas of the brain essential for cognitive function. Plaques are formed mostly from the deposition β-amyloid (Aβ), a peptide derived from the amyloid precursor protein (APP). Filamentous tangles are formed from paired helical filaments composed of neurofilament and hyperphosphorilated tau protein, a microtubule-associated protein. In addition, environmental factors can engender the production of cytokines that are closely related to the installation of an inflammatory process that contributes to neuronal death and the development and the progression of AD. In this review we focus on the recent main contribuitions of natural products chemistry to the discovery of new chemical entities usefull to the control and prevention of AD installation and progression. More than sixteen plant species, including Ginseng, Celastrus paniculatus, Centella asiatica, Curcuma longa, Ginkgo biloba, Huperzia serrata, Lycoris radiate, Galanthus nivalis, Magnolia officinalis, Polygala tenuifolia, Salvia lavandulaefolia, Salvia miltiorrhiza, Coptis chinensis, Crocus sativus, Evodia rutaecarpa, Sanguisorba officinalis, Veratrum grandiflorum and Picrorhiza kurvoa, are discussed as potential sources of active extracts. In addition, more than sixty secondary metabolites are under evaluation for their efficacy on controlling symptoms and to impede the development and progression of AD.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Centella asiatica may have a role in Alzheimer's disease treatment and prevention.
“In vitro research studies utilizing madasiatic acid, madecassoside, asiatic acid, and asiaticosides C. asiatica derivatives have elucidated that these compounds have the ability to block hydrogen peroxide and beta-amyloid-induced cellular death, as well as to reduce the concentration of free radicals, thereby proposing a possible role for C. asiatica in AD treatment and prevention [64,132,133].”
From The Multifaceted Role of Neuroprotective Plants in Alzheimer’s Disease Treatment (2022) · cites this paper as [133]
Cites
1 retracted
Thiruchelvam, M., Prokopenko, O., Cory-Slechta, D., Richfield, E., Buckley, B., & Mirochnitchenko, O. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500417200 · Cited by 84 · see citing works
RetractedNatural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517 · see citing works
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469 · see citing works
Therapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958 · see citing works
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565 · see citing works
Natural products as sources of new drugs over the period 1981–2002
Newman, D. J., Cragg, G. M., & Snader, K. M. (2003) · Journal of Natural Products · doi:10.1021/np030096l · Cited by 3,082 · see citing works
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
Epstein, F. H., Lipton, S. A., & Rosenberg, P. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300907 · Cited by 2,644 · see citing works
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
Dorsey, E. R., Constantinescu, R., Thompson, J. P., Biglan, K., Holloway, R. G., Kieburtz, K. D., Marshall, F. J., Ravina, B. M., Schifitto, G., Siderowf, A. D., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000247740.47667.03 · Cited by 2,479 · see citing works
Brain Lesions, Obesity, and Other Disturbances in Mice Treated with Monosodium Glutamate
Olney, J. (1969) · Science · doi:10.1126/science.164.3880.719 · Cited by 1,885 · see citing works
Medicinal natural products: A biosynthetic approach
(2001) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(01)01302-2 · Cited by 1,698 · see citing works
Biological effects of resveratrol
Frémont, L. (2000) · Life Sciences · doi:10.1016/s0024-3205(99)00410-5 · Cited by 1,663 · see citing works
Natural Products in Drug Discovery and Development
Cragg, G. M. L., Newman, D. J., & Snader, K. M. (1997) · Journal of Natural Products · doi:10.1021/np9604893 · Cited by 1,589 · see citing works
Regulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561 · see citing works
Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.103 · Cited by 1,380 · see citing works
Kaminska, B. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.08.017 · Cited by 1,285 · see citing works
Mitochondrial Genetics: A Paradigm for Aging and Degenerative Diseases?
Wallace, D. C. (1992) · Science · doi:10.1126/science.1533953 · Cited by 1,256 · see citing works
Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro
Ono, K., Hasegawa, K., Naiki, H., & Yamada, M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20025 · Cited by 1,254 · see citing works
Kim, D., Nguyen, M. D., Dobbin, M. M., Fischer, A., Sananbenesi, F., Rodgers, J. T., Delalle, I., Baur, J. A., Sui, G., Armour, S. M., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601758 · Cited by 1,074 · see citing works
Diagnosis and Treatment of Alzheimer Disease and Related Disorders
Small, G. W. (1997) · JAMA · doi:10.1001/jama.1997.03550160083043 · Cited by 984 · see citing works
A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia
Le Bars, P. L. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550160047037 · Cited by 966 · see citing works
Peters, A., & Vaughan, D. W. (1981) · Springer eBooks · doi:10.1007/978-1-4684-3929-8_1 · Cited by 900 · see citing works
Review on some plants of Indian traditional medicine with antioxidant activity
Scartezzini, P., & Speroni, E. (2000) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(00)00213-0 · Cited by 818 · see citing works
Classic toxin-induced animal models of Parkinson?s disease: 6-OHDA and MPTP
Schober, A. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0938-y · Cited by 803 · see citing works
Freund-Levi, Y., Eriksdotter-Jönhagen, M., Cederholm, T., Basun, H., Faxén-Irving, G., Garlind, A., Vedin, I., Vessby, B., Wahlund, L.-O., & Palmblad, J. (2006) · Archives of Neurology · doi:10.1001/archneur.63.10.1402 · Cited by 751 · see citing works
Resveratrol Promotes Clearance of Alzheimer's Disease Amyloid-β Peptides
Marambaud, P., Zhao, H., & Davies, P. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508246200 · Cited by 750 · see citing works
SIRT1 Protects against Microglia-dependent Amyloid-β Toxicity through Inhibiting NF-κB Signaling
Chen, J., Zhou, Y., Mueller-Steiner, S., Chen, L.-F., Kwon, H., Yi, S., Mucke, L., & Gan, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509329200 · Cited by 740 · see citing works
Missing pieces in the Parkinson's disease puzzle
Obeso, J. A., Rodríguez‐Oroz, M., Goetz, C. G., Marin, C. A., Kordower, J. H., Rodrı́guez, M., Hirsch, É. C., Farrer, M. J., Schapira, A. H. V., & Halliday, G. M. (2010) · Nature Medicine · doi:10.1038/nm.2165 · Cited by 737 · see citing works
Neurotransmitter enzyme abnormalities in senile dementia
Perry, E. K., Gibson, P. H., Blessed, G., Perry, R. H., & Tomlinson, B. E. (1977) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(77)90073-9 · Cited by 724 · see citing works
Natural Products as Leads to Potential Drugs: An Old Process or the New Hope for Drug Discovery?
Newman, D. J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm0704090 · Cited by 716 · see citing works
β-Amyloid-mediated vasoactivity and vascular endothelial damage
Thomas, T., Thomas, G., McLendon, C., Sutton, T., & Mullan, M. (1996) · Nature · doi:10.1038/380168a0 · Cited by 703 · see citing works
Ramassamy, C. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.025 · Cited by 680 · see citing works
Schapira, A. H. V., Mann, V. M., Cooper, J. A. D., Dexter, D. T., Daniel, S. E., Jenner, P. G., Clark, J. B., & MARSDEN, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb05809.x · Cited by 673 · see citing works
Ginkgo biloba for Prevention of Dementia A Randomized Controlled Trial
DeKosky, S. T. (2008) · JAMA · doi:10.1001/jama.2008.683 · Cited by 671 · see citing works
Stolk, J. N., Hiltermann, T. J. N., Dijkman, J. H., & Verhoeven, A. J. (1994) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.11.1.8018341 · Cited by 650 · see citing works
Diagnosis and treatment of Parkinson disease: molecules to medicine
Savitt, J. M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29178 · Cited by 649 · see citing works
Wilcock, G. K., Lilienfeld, S., & Gaens, E. (2000) · BMJ · doi:10.1136/bmj.321.7274.1445 · Cited by 623 · see citing works
Environmental risk factors and Parkinson's disease
Liou, H., Tsai, M.-C., Chen, C., Jeng, J., Chang, Y. C., Chen, S. Y., & Chen, R.-T. (1997) · Neurology · doi:10.1212/wnl.48.6.1583 · Cited by 616 · see citing works
Antioxidant activities of polyphenols from sage (Salvia officinalis)
Lu, Y., & Foo, L. Y. (2001) · Food Chemistry · doi:10.1016/s0308-8146(01)00198-4 · Cited by 591 · see citing works
Abramov, A. Y., Canevari, L., & Duchen, M. R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4042-03.2004 · Cited by 587 · see citing works
The Efficacy of Ginkgo biloba on Cognitive Function in Alzheimer Disease
Oken, B., Storzbach, D. M., & Kaye, J. A. (1998) · Archives of Neurology · doi:10.1001/archneur.55.11.1409 · Cited by 585 · see citing works
Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid ß-protein
Selkoe, D. J. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3111 · Cited by 538 · see citing works
Resveratrol protects against global cerebral ischemic injury in gerbils
Wang, Q., Xu, J., Rottinghaus, G. E., Simonyi, Á., Lubahn, D. E., Sun, G. Y., & Sun, A. Y. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03543-6 · Cited by 528 · see citing works
Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area.
Orgogozo, J. M., Dartigues, J. F., Lafont, S., Letenneur, L., Commenges, D., Salamon, R., Renaud, S., & Breteler, M. M. B. (1997) · PubMed · Cited by 525 · see citing works
Chemical, pharmacological and clinical profile of the East Asian medical plant Centella aslatica
Brinkhaus, B., Lindner, M., Schuppan, D., & Hahn, E. G. (2000) · Phytomedicine · doi:10.1016/s0944-7113(00)80065-3 · Cited by 525 · see citing works
Recent Natural Products Based Drug Development: A Pharmaceutical Industry Perspective
Shu, Y. (1998) · Journal of Natural Products · doi:10.1021/np9800102 · Cited by 518 · see citing works
Thiruchelvam, M. J., Richfield, E. K., Baggs, R. B., Tank, A. W., & Cory‐Slechta, D. A. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09207.2000 · Cited by 471 · see citing works
A Hundred Years of Alzheimer's Disease Research
Hardy, J. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.016 · Cited by 467 · see citing works
Perry, N. S. L., Houghton, P. J., Theobald, A. E., Jenner, P. G., & Perry, E. K. (2000) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357001774598 · Cited by 458 · see citing works
Howes, M. R., & Houghton, P. J. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00128-x · Cited by 443 · see citing works
Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases
Mandel, S. A., & Youdim, M. B. H. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.04.012 · Cited by 443 · see citing works
Distinct Role for Microglia in Rotenone-Induced Degeneration of Dopaminergic Neurons
Gao, H., Hong, J., Zhang, W., & Liu, B. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00782.2002 · Cited by 439 · see citing works
Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss
Brooks, A. I., Chadwick, C. A., Gelbard, H. A., Cory‐Slechta, D. A., & Federoff, H. J. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01192-5 · Cited by 425 · see citing works
Howes, M. R., Perry, N. S. L., & Houghton, P. J. (2003) · Phytotherapy Research · doi:10.1002/ptr.1280 · Cited by 418 · see citing works
Advances in the treatment of Parkinson's disease
Singh, N., Pillay, V., & Choonara, Y. E. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.11.009 · Cited by 396 · see citing works
Kuryatov, A. (1994) · Neuron · doi:10.1016/0896-6273(94)90445-6 · Cited by 385 · see citing works
Perry, N. S. L., Bollen, C. S. C., Perry, E. K., & Ballard, C. G. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00108-4 · Cited by 384 · see citing works
Mandel, S. A., Weinreb, O., Amit, T., & Youdim, M. B. H. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02291.x · Cited by 379 · see citing works
Bastianetto, S., Ramassamy, C., Doré, S., Christen, Y., Poirier, J., & Quirion, R. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00069.x · Cited by 378 · see citing works
Kanowski, S., Herrmann, W., Stephan, K., Wierich, W., & Hörr, R. (1996) · Pharmacopsychiatry · doi:10.1055/s-2007-979544 · Cited by 369 · see citing works
Savelev, S. U., Okello, E. J., Perry, N. S. L., Wilkins, R. M., & Perry, E. K. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00125-4 · Cited by 366 · see citing works
The Functions of Five Distinct Mammalian Phospholipase A2s in Regulating Arachidonic Acid Release
Murakami, M., Shimbara, S., Kambe, T., Kuwata, H., Winstead, M. V., Tischfield, J. A., & Kudo, I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14411 · Cited by 366 · see citing works
NADPH Oxidases of the Brain: Distribution, Regulation, and Function
Infanger, D. W., Sharma, R. V., & Davisson, R. L. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.1583 · Cited by 362 · see citing works
Plant-insect coevolution and inhibition of acetylcholinesterase
Ryan, M. F., & Byrne, O. (1988) · Journal of Chemical Ecology · doi:10.1007/bf01013489 · Cited by 357 · see citing works
Plants and the central nervous system
Carlini, E. A. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00112-6 · Cited by 357 · see citing works
Sinha, K., Chaudhary, G., & Gupta, Y. K. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01691-0 · Cited by 356 · see citing works
Multifunctional Activities of Green Tea Catechins in Neuroprotection
Mandel, S. A., Avramovich‐Tirosh, Y., Reznichenko, L., Zheng, H., Weinreb, O., Amit, T., & Youdim, M. B. H. (2005) · Neurosignals · doi:10.1159/000085385 · Cited by 347 · see citing works
Inflammaging as a prodrome to Alzheimer's disease
Giunta, B., Fernandez, F., Nikolic, W. V., Obregon, D., Rrapo, E., Town, T., & Tan, J. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-51 · Cited by 327 · see citing works
Ono, K., & Yamada, M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03707.x · Cited by 320 · see citing works
Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase
Brown, G. C. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351119 · Cited by 315 · see citing works
Uversky, V. N. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0937-z · Cited by 312 · see citing works
The curcuma antioxidants: pharmacological effects and prospects for future clinical use. A review
Miquel, J., Bernd, A., Sempere, J. M., Dı́az-Alperi, J., & Ramı́rez, A. (2002) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(01)00194-7 · Cited by 309 · see citing works
Bae, E., Han, M. J., Choo, M., Park, S., & Kim, D. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.58 · Cited by 307 · see citing works
Oxidative and Inflammatory Pathways in Parkinson’s Disease
Miller, R. L., James-Kracke, M., Sun, G. Y., & Sun, A. Y. (2009) · Neurochemical Research · doi:10.1007/s11064-008-9656-2 · Cited by 306 · see citing works
Gao, H., Liu, B., Zhang, W., & Hong, J. (2003) · The FASEB Journal · doi:10.1096/fj.03-0109fje · Cited by 306 · see citing works
Wesnes, K. A., Ward, T., McGinty, A., & Petrini, O. (2000) · Psychopharmacology · doi:10.1007/s002130000533 · Cited by 305 · see citing works
Cytotoxicity, antioxidant and anti-inflammatory activities of Curcumins I–III from Curcuma longa
Ramsewak, R. S., DeWitt, D. L., & Nair, M. G. (2000) · Phytomedicine · doi:10.1016/s0944-7113(00)80048-3 · Cited by 302 · see citing works
Han, Y.-S., Zheng, W., Bastianetto, S., Chabot, J., & Quirion, R. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705688 · Cited by 300 · see citing works
Wang, J., Ho, L., Zhao, Z., Seror, I., Humala, N., Dickstein, D. L., Thiyagarajan, M., Percival, S. S., Talcott, S. T., & Pasinetti, G. M. (2006) · The FASEB Journal · doi:10.1096/fj.06-6281com · Cited by 299 · see citing works
Antidepressant activity of aqueous extracts of Curcuma longa in mice
Yu, Z. F., Kong, L., & Chen, Y. (2002) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(02)00211-8 · Cited by 293 · see citing works
Antioxidant Action of Ginkgo Biloba Extract (EGB 761)
Packer, L. (1997) · Springer eBooks · doi:10.1007/978-1-4899-1837-6_7 · Cited by 291 · see citing works
Signal integration between IFNγ and TLR signalling pathways in macrophages
Schroder, K., Sweet, M. J., & Hume, D. A. (2006) · Immunobiology · doi:10.1016/j.imbio.2006.05.007 · Cited by 288 · see citing works
A Reassessment of the Low Molecular Weight Phospholipase A2 Gene Family in Mammals
Tischfield, J. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17247 · Cited by 284 · see citing works
Shelat, P. B., Chalimoniuk, M., Wang, J., Strosznajder, J. B., Lee, J. C., Sun, A. Y., Simonyi, Á., & Sun, G. Y. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05347.x · Cited by 283 · see citing works
Park, S., & Kim, D. S. H. L. (2002) · Journal of Natural Products · doi:10.1021/np010039x · Cited by 278 · see citing works
Beal, M. F. (2004) · Journal of Bioenergetics and Biomembranes · doi:10.1023/b:jobb.0000041772.74810.92 · Cited by 276 · see citing works
Semchuk, K. M., Love, E. J., & Lee, R. G. (1993) · Neurology · doi:10.1212/wnl.43.6.1173 · Cited by 275 · see citing works
Resveratrol inhibits nitric oxide and TNF-α production by lipopolysaccharide-activated microglia
Bi, X. L., Yang, J., Dong, Y. X., Wang, J., Cui, Y. H., Ikeshima, T., Zhao, Y. Q., & Wu, C. F. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.08.008 · Cited by 274 · see citing works
Use of Ginseng in Medicine With Emphasis on Neurodegenerative Disorders
Radad, K., Gille, G., Liu, L., & Rausch, W. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.crj05010x · Cited by 268 · see citing works
Oxidative and Antioxidative Potential of Brain Microglial Cells
Dringen, R. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.1223 · Cited by 266 · see citing works
Kim, D. S. H. L., Park, S., & Kim, J.-Y. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01677-9 · Cited by 262 · see citing works
Chun, H. S., Gibson, G. E., DeGiorgio, L. A., Zhang, H., Kidd, V. J., & Son, J. H. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00096.x · Cited by 256 · see citing works
Kennedy, D. O., Scholey, A. B., & Wesnes, K. A. (2000) · Psychopharmacology · doi:10.1007/s002130000501 · Cited by 255 · see citing works
Gao, H., Hong, J., Zhang, W., & Liu, B. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-04-01228.2003 · Cited by 251 · see citing works
Bores, G. M., Huger, F. P., Petko, W. W., Mutlib, A. E., Camacho, F., Rush, D. K., Selk, D. E., Wolf, V., Kosley, R. W., Davis, L., et al. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12928-5 · Cited by 249 · see citing works
Sources and Targets of Reactive Oxygen Species in Synaptic Plasticity and Memory
Kishida, K. T., & Klann, E. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.9.ft-8 · Cited by 245 · see citing works
Ginseng: potential for the enhancement of cognitive performance and mood
Kennedy, D. O., & Scholey, A. B. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00126-6 · Cited by 245 · see citing works
Protective action of seven natural phenolic compounds against peroxidative damage to biomembranes
Liu, G.-T., Zhang, T., Wang, B.-E., & Wang, Y. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90271-j · Cited by 244 · see citing works
Pietri, S., Maurelli, E., Drieu, K., & Culcasi, M. (1997) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0316 · Cited by 236 · see citing works
Nuclear import of PKCδ is required for apoptosis: identification of a novel nuclear import sequence
DeVries, T. A., Neville, M. C., & Reyland, M. E. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf606 · Cited by 236 · see citing works
Chemical Constituents of Polygonaceous Plants. I
Nonomura, S., Kanagawa, H., & Makimoto, A. (1963) · YAKUGAKU ZASSHI · doi:10.1248/yakushi1947.83.10_988 · Cited by 233 · see citing works
Inoue, H., Jiang, X., Katayama, T., Osada, S., Umesono, K., & Namura, S. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.09.001 · Cited by 232 · see citing works
Pesticides and Risk of Parkinson Disease
Firestone, J. A., Smith‐Weller, T., Franklin, G. M., Swanson, P. D., Longstreth, W. T., Jr., & Checkoway, H. (2005) · Archives of Neurology · doi:10.1001/archneur.62.1.91 · Cited by 232 · see citing works
Botanical Phenolics and Brain Health
Sun, A. Y., Wang, Q., Simonyi, Á., & Sun, G. Y. (2008) · NeuroMolecular Medicine · doi:10.1007/s12017-008-8052-z · Cited by 225 · see citing works
Hirai, H., Kirsch, J., Laube, B., Betz, H., & Kuhse, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.6031 · Cited by 223 · see citing works
Bastianetto, S., Zheng, W., & Quirion, R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742268.x · Cited by 222 · see citing works
Lima, T., Waffo‐Téguo, P., Teissèdre, P., Pujolas, A., Vercauteren, J., Cabanis, J. C., & Mérillon, J. (1999) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf9900884 · Cited by 220 · see citing works
Neuroprotection by resveratrol against traumatic brain injury in rats
Ateş, Ö., Cayli, S. R., Altınöz, E., Gürses, İ., Yücel, N., Sener, M., Koçak, A., & Yoloğlu, S. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9253-0 · Cited by 219 · see citing works
Anantharam, V., Kitazawa, M., Wagner, J. R., Kaul, S., & Kanthasamy, A. G. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01738.2002 · Cited by 219 · see citing works
Mechanisms of MAPK signalling specificity
Bardwell, L. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340837 · Cited by 213 · see citing works
Inhibition of Acetylcholinesterase Activity by Monoterpenoids with a p-Menthane Skeleton
Miyazawa, M., Watanabe, H., & Kameoka, H. (1997) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf960398b · Cited by 210 · see citing works
Curcumin (diferuloylmethane), a singlet oxygen (1O2) quencher
Das, K. C., & Das, C. K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00633-2 · Cited by 208 · see citing works
Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells
Chanvitayapongs, S., Draczynska‐Lusiak, B., & Sun, A. Y. (1997) · Neuroreport · doi:10.1097/00001756-199704140-00035 · Cited by 206 · see citing works
A mechanism of paraquat toxicity involving nitric oxide synthase
Day, B. J., Patel, M., Calavetta, L., Chang, L.-Y., & Stamler, J. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12760 · Cited by 206 · see citing works
Srivastava, K. C., Bordia, A., & Verma, S. K. (1995) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(95)90040-3 · Cited by 204 · see citing works
Microglia Proliferation Is Regulated by Hydrogen Peroxide from NADPH Oxidase
Mander, P. K., Jekabsone, A., & Brown, G. C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.1046 · Cited by 198 · see citing works
Determination of biologically active constituents in Centella asiatica
Inamdar, P. K., Yeole, R. D., Ghogare, A. B., & SOUZA, N. J. D. (1996) · Journal of Chromatography A · doi:10.1016/0021-9673(96)00237-3 · Cited by 197 · see citing works
Zhao, B., Jiang, W., Zhao, Y., Hou, J. W., & Xin, W. J. (1996) · PubMed · Cited by 193 · see citing works
Anti-anxiety studies on extracts of Passiflora incarnata Linneaus
Dhawan, K., Kumar, S., & Sharma, A. (2001) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(01)00339-7 · Cited by 192 · see citing works
Akao, T., Kanaoka, M., & Kobashi, K. (1998) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.21.245 · Cited by 189 · see citing works
Resveratrol: A Natural Compound with Pharmacological Potential in Neurodegenerative Diseases
Rocha-González, H. I., Ambriz‐Tututi, M., & Granados‐Soto, V. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00045.x · Cited by 187 · see citing works
Tokuşoğlu, Ö., Ünal, M. K., & Yemiş, F. (2005) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf050496+ · Cited by 183 · see citing works
Schneider, L. S., DeKosky, S. T., Farlow, M. R., Tariot, P. N., Hoerr, R., & Kieser, M. (2005) · Current Alzheimer Research · doi:10.2174/156720505774932287 · Cited by 182 · see citing works
Yao, Z., Drieu, K., & Papadopoulos, V. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03131-0 · Cited by 181 · see citing works
In vitro andin vivo activity of eugenol on human herpesvirus
Benencia, F., & Courr�ges, M. C. (2000) · Phytotherapy Research · doi:10.1002/1099-1573(200011)14:7 · Cited by 181 · see citing works
Free Radical Reactions of Curcumin in Membrane Models
Priyadarsini, K. I. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(97)00026-9 · Cited by 174 · see citing works
Butterfield, D. A., Griffin, S. T., Münch, G. W., & Pasinetti, G. M. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4309 · Cited by 174 · see citing works
Os produtos naturais e a química medicinal moderna
Viegas, C., Bolzani, V. D. S., & Barreiro, E. J. (2006) · Química Nova · doi:10.1590/s0100-40422006000200025 · Cited by 173 · see citing works
Self-citationBey, E. A., Xu, B., Bhattacharjee, A., Oldfield, C. M., Zhao, X., Li, Q., Subbulakshmi, V., Feldman, G. M., Wientjes, F. B., & Cathcart, M. K. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5730 · Cited by 172 · see citing works
Rajeswari, A., & Sabesan, M. (2008) · Inflammopharmacology · doi:10.1007/s10787-007-1614-0 · Cited by 170 · see citing works
The pharmacology of galanthamine and its analogues
Harvey, A. L. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)02002-0 · Cited by 169 · see citing works
Kumar, P., Padi, S. S., Naidu, P. S., & Kumar, A. (2006) · Behavioural Pharmacology · doi:10.1097/00008877-200609000-00014 · Cited by 167 · see citing works
Evaluation In Vitro of Plant Essential Oils as Natural Antioxidants
Dorman, H. J. D., Deans, S. G., Noble, R. C., & Surai, P. F. (1995) · Journal of Essential Oil Research · doi:10.1080/10412905.1995.9700520 · Cited by 166 · see citing works
Soulimani, R., Younos, C., Jarmouni, I. S., Bousta, D., Misslin, R., & Mortier, F. (1997) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(97)00042-1 · Cited by 165 · see citing works
Bars, P. L. L., Kieser, M., & Itil, K. Z. (2000) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017242 · Cited by 164 · see citing works
Membrane Phospholipid Alterations In Alzheimer's Disease: Deficiency of Ethanolamine Plasmalogens
Farooqui, A. A., Rapoport, S. I., & Horrocks, L. A. (1997) · Neurochemical Research · doi:10.1023/a:1027380331807 · Cited by 163 · see citing works
Barbieri, S. S., Cavalca, V., Eligini, S., Brambilla, M., Caiani, A., Tremoli, E., & Colli, S. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.04.020 · Cited by 161 · see citing works
Peng, J., Stevenson, F. F., Doctrow, S. R., & Andersen, J. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500984200 · Cited by 159 · see citing works
In-vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease
Perry, N. S. L., Houghton, P. J., Sampson, J., Theobald, A. E., Hart, S., Lis‐Balchin, M., Hoult, J. R. S., Evans, P., Jenner, P. G., Milligan, S. R., et al. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011777846 · Cited by 159 · see citing works
Casarejos, M. J., Menéndez, J., Solano, R. M., Rodríguez‐Navarro, J. A., de Yébenes, J. G., & Mena, M. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03777.x · Cited by 156 · see citing works
Flavonoid‐mediated presenilin‐1 phosphorylation reduces Alzheimer's disease β‐amyloid production
Rezai-Zadeh, K. P., Shytle, R. D., Bai, Y., Tian, J., Hou, H., Mori, T., Zeng, J., Obregon, D. F., Town, T., & Tan, J. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00344.x · Cited by 153 · see citing works
Kennedy, D. O., Scholey, A. B., & Wesnes, K. A. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00665-0 · Cited by 150 · see citing works
Resistance to Endotoxic Shock in Endothelial Nitric-oxide Synthase (eNOS) Knock-out Mice
Connelly, L., Madhani, M., & Hobbs, A. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411991200 · Cited by 149 · see citing works
Karikura, M., Miyase, T., Tanizawa, H., TANIYAMA, T., & Takino, Y. (1991) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.39.2357 · Cited by 148 · see citing works
Fessenden, J., Wittenborn, W., & Clarke, L. E. (2001) · The American Surgeon · doi:10.1177/000313480106700108 · Cited by 147 · see citing works
Kumar, A., Naidu, P. S., Seghal, N., & Padi, S. S. V. (2006) · Pharmacology · doi:10.1159/000097511 · Cited by 147 · see citing works
Mechanism of inhibition of cholinesterases by huperzine A
Ashani, Y., Peggins, J. O., & Doctor, B. P. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90649-6 · Cited by 144 · see citing works
S, G., Shovlin, C. L., & Wesnes, K. A. (1991) · Current Medical Research and Opinion · doi:10.1185/03007999109111504 · Cited by 144 · see citing works
Park, C., Kim, S., Choi, W., Lee, Y. J., Kim, J., Kang, S. S., & Sun, Y. (1996) · Planta Medica · doi:10.1055/s-2006-957926 · Cited by 143 · see citing works
Soldati, F., & Sticher, O. (1980) · Planta Medica · doi:10.1055/s-2008-1074929 · Cited by 140 · see citing works
Bushnell, D. M., & Martin, M. L. (1999) · Quality of Life Research · doi:10.1023/a:1008979705027 · Cited by 139 · see citing works
Shimizu, K., Matsubara, K., Ohtaki, K., Fujimaru, S., Saito, O., & Shiono, H. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02750-1 · Cited by 139 · see citing works
Kennedy, D. O., Scholey, A. B., & Wesnes, K. A. (2001) · Nutritional Neuroscience · doi:10.1080/1028415x.2001.11747370 · Cited by 138 · see citing works
NADPH oxidase is required for NMDA receptor‐dependent activation of ERK in hippocampal area CA1
Kishida, K. T., Pao, M., Holland, S. M., & Klann, E. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03189.x · Cited by 135 · see citing works
Hofferberth, B. (1994) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470090308 · Cited by 134 · see citing works
Antioxidant property of Celastrus paniculatus Willd.: A possible mechanism in enhancing cognition
Kumar, M. H. V., & Gupta, Y. K. (2002) · Phytomedicine · doi:10.1078/0944-7113-00136 · Cited by 133 · see citing works
Park, C. H., Choi, S. H., Koo, J., Seo, J., Kim, H., Jeong, S., & Suh, Y. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10429 · Cited by 131 · see citing works
Zupkó, I., Hohmann, J., Rédei, D., Falkay, G., Janicsák, G., & Máthé, I. (2001) · Planta Medica · doi:10.1055/s-2001-14327 · Cited by 129 · see citing works
Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia–reperfusion in mice
Gao, D., Zhang, X., Jiang, X., Peng, Y., Huang, W., Cheng, G. S., & Song, L. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.10.030 · Cited by 129 · see citing works
Stoll, S., Scheuer, K., Pohl, O., & Müller, W. E. G. (2007) · Pharmacopsychiatry · doi:10.1055/s-2007-979561 · Cited by 128 · see citing works
Benedetto, A., Au, C., & Aschner, M. (2009) · Chemical Reviews · doi:10.1021/cr800536y · Cited by 127 · see citing works
Coma in a patient with Alzheimer's disease taking low dose trazodone and Ginkgo biloba
GALLUZZI, S. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.5.679a · Cited by 125 · see citing works
Synergistic protection of PC12 cells from β-amyloid toxicity by resveratrol and catechin
Conte, A., Pellegrini, S., & Tagliazucchi, D. (2003) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2003.08.001 · Cited by 124 · see citing works
Cohort analysis of Parkinson's syndrome
Poskanzer, D. C., & Schwab, R. S. (1963) · Journal of Chronic Diseases · doi:10.1016/0021-9681(63)90098-5 · Cited by 122 · see citing works
Wen, T., Yoshimura, H., Matsuda, S., Lim, J.-H., & Sakanaka, M. (1995) · Acta Neuropathologica · doi:10.1007/s004010050387 · Cited by 122 · see citing works
Oxidative stress mechanisms and potential therapeutics in Alzheimer disease
Moreira, P. I., Siedlak, S. L., Aliev, G., Zhu, X., Cash, A., Smith, M. A., & Perry, G. L. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0242-8 · Cited by 116 · see citing works
Ved, H. S., Koenig, M. L., Dave, J. R., & Doctor, B. P. (1997) · Neuroreport · doi:10.1097/00001756-199703030-00029 · Cited by 116 · see citing works
Protein kinase C isoforms as therapeutic targets in nervous system disease states
Battaini, F. (2001) · Pharmacological Research · doi:10.1006/phrs.2001.0893 · Cited by 115 · see citing works
Chandrasekaran, K., Mehrabian, Z., Spinnewyn, B., Drieu, K., & Fiskum, G. M. (2001) · Brain Research · doi:10.1016/s0006-8993(01)03188-2 · Cited by 112 · see citing works
Doré, S. (2005) · Neurosignals · doi:10.1159/000085386 · Cited by 112 · see citing works
Yang, W., & Tiffany‐Castiglioni, E. (2005) · Journal of Toxicology and Environmental Health · doi:10.1080/15287390500226987 · Cited by 112 · see citing works
Do NSAIDs prevent Alzheimer's disease? And, if so, why? The epidemiological evidence.
Zandi, P., & Breitner, J. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00297-4 · Cited by 112 · see citing works
Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease?
Maguire‐Zeiss, K. A., Short, D. W., & Federoff, H. J. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.09.014 · Cited by 111 · see citing works
Improvement in organically disturbed behavior with trazodone treatment.
Simpson, D. M., & Foster, D. (1986) · PubMed · Cited by 108 · see citing works
Schindowski, K., Leutner, S., Kressmann, S., Eckert, A., & Müller, W. E. G. (2001) · Journal of Neural Transmission · doi:10.1007/s007020170016 · Cited by 106 · see citing works
Chopin, P., & Briley, M. (1992) · Psychopharmacology · doi:10.1007/bf02253584 · Cited by 105 · see citing works
Anti-inflammatory and analgesic effects of magnolol
Wang, J.-P., Hsu, M., Raung, S.-Z., Chen, C., Kuo, J., & Teng, C. (1992) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00168746 · Cited by 103 · see citing works
Miloso, M., Bertelli, A. A. E., Nicolini, G., & Tredici, G. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00194-9 · Cited by 101 · see citing works
Wiring diagrams of MAPK regulation by MEKK1, 2, and 3
Uhlik, M. T., Abell, A. N., Cuevas, B. D., Nakamura, K., & Johnson, G. L. (2004) · Biochemistry and Cell Biology · doi:10.1139/o04-114 · Cited by 101 · see citing works
Kennedy, D. O., Scholey, A. B., & Wesnes, K. A. (2001) · Nutritional Neuroscience · doi:10.1080/1028415x.2001.11747376 · Cited by 100 · see citing works
Evaluation of Commercial Ginseng Products
Liberti, L. E., & Marderosian, A. D. (1978) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600671050 · Cited by 100 · see citing works
Resveratrol protects SH-SY5Y neuroblastoma cells from apoptosis induced by dopamine
Lee, M. K., Kang, S. J., Poncz, M., Song, K., & Park, K. S. (2007) · Experimental & Molecular Medicine · doi:10.1038/emm.2007.42 · Cited by 99 · see citing works
Neuropathology of Parkinson’s Disease and Related Syndromes
Gibb, W. R. G. (1992) · Neurologic Clinics · doi:10.1016/s0733-8619(18)30215-9 · Cited by 99 · see citing works
Ikeya, Y., Takeda, S., Tunakawa, M., Karakida, H., Toda, K., Yamaguchi, T., & Aburada, M. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.1081 · Cited by 98 · see citing works
Mitogen-activated protein kinase (MAPK)
Cuschieri, J., & Maier, R. V. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000191714.39495.a6 · Cited by 96 · see citing works
Pharmacokinetics of galanthamine in humans and corresponding cholinesterase inhibition
Bickel, U., Thomsen, T., Weber, W., Fischer, J. P., Bachus, R., Nitz, M., & Kewitz, H. (1991) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1991.159 · Cited by 94 · see citing works
Alvira, D., Yeste‐Velasco, M., Folch, J., Verdaguer, E., Canudas, A. M., Pallàs, M., & Camins, A. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.04.029 · Cited by 93 · see citing works
Topic, B., Tani, E., Tsiakitzis, K. C., Kourounakis, P. N., Dere, E., Hasenöhrl, R. U., Häcker, R., Mattern, C., & Huston, J. P. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00241-x · Cited by 90 · see citing works
Huperzine A protects rat pheochromocytoma cells against hydrogen peroxide-induced injury
Xiao, X., Yang, J., & Tang, X. C. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00695-3 · Cited by 90 · see citing works
Paraquat leads to dopaminergic neural vulnerability in organotypic midbrain culture
Shimizu, K., Matsubara, K., Ohtaki, K., & Shiono, H. (2003) · Neuroscience Research · doi:10.1016/s0168-0102(03)00163-9 · Cited by 89 · see citing works
Jia, H., Jiang, Y., Ruan, Y., Zhang, Y., Ma, X., Zhang, J., Beyreuther, K. T., Tu, P., & Zhang, D. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.05.093 · Cited by 88 · see citing works
Kim, Y., Lim, S., Rhee, S., Park, K., Kim, C., Choi, B., Lee, S. J., Park, Y., & Choi, Y. H. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.17.6.1069 · Cited by 88 · see citing works
Wang, J.-P., Ho, T., Chang, L., & Chen, C. (1995) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1995.tb05754.x · Cited by 85 · see citing works
Current Treatment and Recent Clinical Research in Alzheimer's Disease
Neugroschl, J. A., & Sano, M. (2010) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20165 · Cited by 83 · see citing works
Seif-El-Nasr, M., & ABDELFATTAH, A. (1995) · Pharmacological Research · doi:10.1016/s1043-6618(05)80014-3 · Cited by 82 · see citing works
Gravel, M., Polo, A. D., Valera, P. B., & Braun, P. E. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19980815)53:4 · Cited by 82 · see citing works
Pharmacologic treatment of Alzheimer's disease: an update.
DeLaGarza, V. W. (2003) · PubMed · Cited by 82 · see citing works
Huperzine A improves cognitive deficits caused by chronic cerebral hypoperfusion in rats
Wang, L., Han, Y., & Tang, X. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00291-0 · Cited by 81 · see citing works
Nalini, K., Karanth, K. S., Rao, A., & Aroor, A. R. (1995) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(95)01264-e · Cited by 81 · see citing works
Cerebral Protective and Cognition-Improving Effects of Sinapic Acid in Rodents
Karakida, F., Ikeya, Y., 綱川, 光., Yamaguchi, T., Ikarashi, Y., Takeda, S., & Aburada, M. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.514 · Cited by 78 · see citing works
Cholinesterase inhibition by galanthamine and lycoramine
Irwin, R. L., & Smith, H. J. (1960) · Biochemical Pharmacology · doi:10.1016/0006-2952(60)90030-7 · Cited by 78 · see citing works
Flagged first, then by citations
3 of the 294 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Medicinal plants in Brazil: Pharmacological studies, drug discovery, challenges and perspectives
Dutra, R. C., Campos, M. M., Santos, A. R. S., & Calixto, J. Β. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.01.021 · Cited by 439 · see citing works
Potential Impact of the Multi-Target Drug Approach in the Treatment of Some Complex Diseases
Makhoba, X. H., Viegas, C., Mosa, R. A., Viegas, F. P. D., & Pooe, O. J. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s257494 · Cited by 333 · see citing works
Self-citationNeuroprotective Herbs for the Management of Alzheimer’s Disease
Gregory, J., Vengalasetti, Y. V., Bredesen, D. E., & Rao, R. V. (2021) · Biomolecules · doi:10.3390/biom11040543 · Cited by 238 · see citing works
Dey, A., Bhattacharya, R., Mukherjee, A., & Pandey, D. K. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.12.005 · Cited by 232 · see citing works
Parkinson’s Disease: A Review from Pathophysiology to Treatment
Marino, B. L. B., de Souza, L. R., Sousa, K. P. A., Ferreira, J. V., Padilha, E. C., da Silva, C. H. T. D. P., Taft, C. A., & Hage-Melim, L. I. D. S. (2019) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557519666191104110908 · Cited by 228 · see citing works
Ayurvedic medicinal plants for Alzheimer’s disease: A review
Rao, R. V., Descamps, O., John, V., & Bredesen, D. E. (2012) · Alzheimer's Research & Therapy · doi:10.1186/alzrt125 · Cited by 213 · see citing works
Ma, H., Johnson, S. L., Liu, W., DaSilva, N. A., Meschwitz, S. M., Dain, J. A., & Seeram, N. P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020461 · Cited by 179 · see citing works
Dias, K. S. T., & Viegas, C. (2014) · Current Neuropharmacology · doi:10.2174/1570159x1203140511153200 · Cited by 174 · see citing works
Self-citationAhmad, R. S., Hussain, M. B., Sultan, M. T., Arshad, M. S., Waheed, M., Shariati, M. A., Plygun, S., & Hashempur, M. H. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/7656919 · Cited by 166 · see citing works
Coumarins as cholinesterase inhibitors: A review
de Souza, L. G., Rennó, M. N., & Figueroa‐Villar, J. D. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.05.001 · Cited by 162 · see citing works
Olatunji, O. J., Feng, Y., Olatunji, O. O., Tang, J., Ouyang, Z., & Su, Z. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.03.009 · Cited by 114 · see citing works
Natural Products As A Rich Source Of Tau-Targeting Drugs For Alzheimer’s Disease
Calcul, L., Zhang, B., Jinwal, U. K., Dickey, C. A., & Baker, B. J. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.124 · Cited by 107 · see citing works
Jung, H. A., Ali, M. Y., Choi, R. J., Jeong, H. O., Chung, H. Y., & Choi, J. S. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.01.014 · Cited by 99 · see citing works
Aalinkeel, R., Kutscher, H. L., Singh, A. K., Cwiklinski, K., Khechen, N., Schwartz, S. A., Prasad, P. N., & Mahajan, S. D. (2017) · Journal of drug targeting · doi:10.1080/1061186x.2017.1354002 · Cited by 97 · see citing works
Sadeghnia, H. R., Kamkar, M., Assadpour, E., Boroushaki, M. T., & Ghorbani, A. (2013) · Europe PMC (PubMed Central) · Cited by 96 · see citing works
Dong, H., Li, R., Yu, C., Xu, T., Zhang, X., & Dong, M. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.11.008 · Cited by 92 · see citing works
Chen, Y., Zhang, D.-Q., Liao, Z., Wang, B., Gong, S., Wang, C., Zhang, M.-Z., Wang, G., Cai, H., Liao, F., et al. (2015) · Molecular Neurodegeneration · doi:10.1186/1750-1326-10-4 · Cited by 93 · see citing works
The Role of Bioactive Compounds on the Promotion of Neurite Outgrowth
More, S. V., Koppula, S., Kim, I., Kumar, H., Kim, B.-W., & Choi, D. (2012) · Molecules · doi:10.3390/molecules17066728 · Cited by 89 · see citing works
Therapeutic Potential of Phytoconstituents in Management of Alzheimer’s Disease
Singh, S. P., Nand, S., Maurya, A., Mishra, G., Awasthi, R., Shakya, A., Chellappan, D. K., Dua, K., Vamanu, E., Chaudhary, S. K., et al. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5578574 · Cited by 75 · see citing works
Lukiw, W. J. (2012) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2012.672559 · Cited by 74 · see citing works
Azizi, G., & Mirshafiey, A. (2012) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2012.705292 · Cited by 72 · see citing works
Cordeiro, L. M., Machado, M. L., da Silva, A. F., Baptista, F. B. O., da Silveira, T. L., Soares, F. A. A., & Arantes, L. P. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111323 · Cited by 69 · see citing works
Zhang, S., Shao, S.-Y., Song, X., Xia, C., Yang, Y., Zhang, P., & Chen, N. (2015) · NeuroToxicology · doi:10.1016/j.neuro.2015.09.009 · Cited by 68 · see citing works
Zhang, G.-F., Zhang, Y., & Zhao, G. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.07.011 · Cited by 67 · see citing works
Antibody-Based Drugs and Approaches Against Amyloid-β Species for Alzheimer’s Disease Immunotherapy
Liu, J., Yang, B., Ke, J., Li, W., & Suen, W.-C. (2016) · Drugs & Aging · doi:10.1007/s40266-016-0406-x · Cited by 67 · see citing works
Priglinger, E., Urmann, C., Steffenhagen, C., Bieler, L., Brunner, D., Furtner, T., Humpel, C., Bäumer, B. E., Bandtlow, C. E., Couillard‐Després, S., et al. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.06.005 · Cited by 65 · see citing works
Zhou, J., Qu, X., Li, Z., Wei-Ji, Liu, Q., Ma, Y., & He, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101668 · Cited by 62 · see citing works
Docking Studies for Multi-Target Drugs
Scotti, L., Mendonça, F. J. B., Ishiki, H. M., Ribeiro, F. F., Singla, R. K., Barbosa‐Filho, J. M., da Silva, M. S., & Scotti, L. (2015) · Current Drug Targets · doi:10.2174/1389450116666150825111818 · Cited by 58 · see citing works
Pharmacological exploration of traditional plants for the treatment of neurodegenerative disorders
Wahid, M., Ali, A., Saqib, F., Aleem, A., Bibi, S., Afzal, K., Ali, A., Baig, A., Khan, S. A., & Asad, M. H. H. B. (2020) · Phytotherapy Research · doi:10.1002/ptr.6742 · Cited by 60 · see citing works
α-Mangostin Inhibits α-Synuclein-Induced Microglial Neuroinflammation and Neurotoxicity
Hu, Z., Wang, W., Jing, L., & Jiang, C. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0264-9 · Cited by 50 · see citing works
Herbal Medicines for Parkinson's Disease: A Systematic Review of Randomized Controlled Trials
Kim, T., Cho, K., Jung, W., & Lee, M. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035695 · Cited by 49 · see citing works
Chakrabortee, S., Liu, Y., Zhang, L., Matthews, H. R., Zhang, H., Pan, N., Cheng, C., Guan, S., Guo, D., Huang, Z., et al. (2011) · Biochemical Journal · doi:10.1042/bj20111661 · Cited by 48 · see citing works
Sechi, S., Chiavolelli, F., Spissu, N., Cerbo, A. D., Canello, S., Guidetti, G., Fiore, F., & Cocco, R. (2015) · Journal of Veterinary Medicine · doi:10.1155/2015/412501 · Cited by 45 · see citing works
Ghobeh, M., Ahmadian, S., Meratan, A. A., Ebrahim‐Habibi, A., Ghasemi, A., Shafizadeh, M., & Nemat‐Gorgani, M. (2014) · Biopolymers · doi:10.1002/bip.22572 · Cited by 45 · see citing works
Arora, N., Shah, K., & Rai, S. P. (2015) · PROTOPLASMA · doi:10.1007/s00709-015-0829-y · Cited by 44 · see citing works
Arel-Dubeau, A.-M., Longpré, F., Bournival, J., Tremblay, C., Demers-Lamarche, J., Hašková, P., Attard, E., Germain, M., & Martinoli, M. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/425496 · Cited by 43 · see citing works
Asiaticoside, a component of Centella asiatica, inhibits melanogenesis in B16F10 mouse melanoma
Kwon, K. J., Bae, S., Kim, K., An, I. S., Ahn, K. J., An, S., & Cha, H. J. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2159 · Cited by 43 · see citing works
A review on α-mangostin as a potential multi-target-directed ligand for Alzheimer's disease
Yang, A., Liu, C., Wu, J., Kou, X., & Shen, R. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173950 · Cited by 40 · see citing works
Therapeutic Potential of Different Natural Products for the Treatment of Alzheimer’s Disease
Chakraborty, B., Mukerjee, N., Maitra, S., Zehravi, M., Mukherjee, D., Ghosh, A., Massoud, E. E. S., & Rahman, M. H. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/6873874 · Cited by 42 · see citing works
Weng, J., Yen, M., & Lin, W. (2013) · Phytochemistry · doi:10.1016/j.phytochem.2013.05.022 · Cited by 38 · see citing works
Phytocannabinoids: General Aspects and Pharmacological Potential in Neurodegenerative Diseases
Franco, G. D. R. R., Smid, S. D., & Viegas, C. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200720172624 · Cited by 36 · see citing works
Self-citationLkhagvasuren, K., & Kim, J. (2019) · Toxicology in Vitro · doi:10.1016/j.tiv.2019.04.028 · Cited by 34 · see citing works
The Rational Discovery of a Tau Aggregation Inhibitor
Baggett, D. W., & Nath, A. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00581 · Cited by 34 · see citing works
Javed, M. N., Dahiya, E. S., Ibrahim, A. M., Alam, M. S., Khan, F. A., & Pottoo, F. H. (2020) · Springer eBooks · doi:10.1007/978-981-15-4909-0_9 · Cited by 30 · see citing works
The Multifaceted Role of Neuroprotective Plants in Alzheimer’s Disease Treatment
Zieneldien, T., Kim, J., & Cao, C. (2022) · Geriatrics · doi:10.3390/geriatrics7020024 · Cited by 29 · see citing works
“asiatica in AD treatment and prevention [64,132,133].”
Chae, U., Min, J., Leem, H. H., Lee, H., Lee, H. J., Lee, S., & Lee, D. (2017) · Pharmacology · doi:10.1159/000477814 · Cited by 28 · see citing works
Baradaran, S., Moghaddam, A. H., & Ghasemi‐Kasman, M. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.07.001 · Cited by 28 · see citing works
He, J., Liang, J., Wang, L., & Hua, X.-D. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.175053 · Cited by 27 · see citing works
Wang, Q., Dong, X., Zhang, R., & Zhao, C. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210735 · Cited by 27 · see citing works
Herbs to curb cyclic nucleotide phosphodiesterase and their potential role in Alzheimer’s disease
Kumar, A., Sharma, V., Singh, V. P., Kaundal, M., Gupta, M., Bariwal, J. B., & Deshmukh, R. R. (2015) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2015.05.009 · Cited by 27 · see citing works
Neurotropic and neuroprotective activities of the earthworm peptide Lumbricusin
Kim, D. H., Lee, I. H., Nam, S. T., Hong, J., Zhang, P., Hwang, J. S., Seok, H., Choi, H., Lee, D. G., Kim, J. I., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.04.105 · Cited by 25 · see citing works
Porres-Martínez, M., González‐Burgos, E., Accame, M. E. C., & Gómez-Serranillos, M. P. (2013) · Food Research International · doi:10.1016/j.foodres.2013.07.029 · Cited by 24 · see citing works
In silico development of new acetylcholinesterase inhibitors
Pascoini, A. L., Federico, L. B., Arêas, A. L. F., Verde, B., de Freitas, P. G., & Camps, I. (2018) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2018.1447513 · Cited by 24 · see citing works
Panwar, S., Uniyal, P., Kukreti, N., Hashmi, A., Verma, S., Arya, A., & Joshi, G. (2024) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14515 · Cited by 23 · see citing works
Talebi, M., Khoramjouy, M., Feizi, A., Ali, Z., Khan, I. A., Ayatollahi, N. A., Ayatollahi, S. A., & Faizi, M. (2023) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2023.100263 · Cited by 22 · see citing works
Sachdeva, P., Narayanan, K. B., Sinha, J. K., Gupta, S. K., Ghosh, S., Singh, D. K. K., Bhaskar, R., Almutary, A. G., Zothantluanga, J. H., Kotta, K. K., et al. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231181 · Cited by 22 · see citing works
Firdaus, Z., & Singh, T. D. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520666200730155928 · Cited by 22 · see citing works
Save, S. N., & Choudhary, S. (2017) · RSC Advances · doi:10.1039/c6ra28440j · Cited by 21 · see citing works
Forestalling the Epidemics of Parkinson's Disease Through Plant-Based Remedies
Banjari, I., Marček, T., Tomić, S., & Waisundara, V. Y. (2018) · Frontiers in Nutrition · doi:10.3389/fnut.2018.00095 · Cited by 21 · see citing works
Baptista, F. B. O., Arantes, L. P., Machado, M. L., da Silva, A. F., Cordeiro, L. M., da Silveira, T. L., & Soares, F. A. A. (2020) · Metallomics · doi:10.1039/d0mt00074d · Cited by 20 · see citing works
Abed, D. A., Lee, S., Wen, X., Ali, A. R., Mangipudy, V. S., Aleksunes, L. M., & Hu, L. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116300 · Cited by 19 · see citing works
Viegas, F. P. D., Gontijo, V. S., Silva, M. D. F., Ortiz, C. J. C., Franco, G. D. R. R., Ernesto, J. T., Damásio, C. M., Silva, I. M. F., Campos, T. G., & Viegas, C. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210712152532 · Cited by 20 · see citing works
Self-citationMyelophil ameliorates brain oxidative stress in mice subjected to restraint stress
Lee, J., Kim, H.-G., Han, J., Lee, J.-S., Son, S., Ahn, Y., & Son, C. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.07.006 · Cited by 19 · see citing works
Lee, J. S., Kim, J. H., Han, Y. K., Yeul, J., Kim, Y. H., Li, W., & Yang, S. Y. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.09.014 · Cited by 19 · see citing works
Tabrizian, K., Musavi, S., Rigi, M., Hosseindadi, F., Kordi, S., Shamshirgaran, F., Bazı, A., Shahraki, J., Rezaee, R., & Hashemzaei, M. (2019) · Human & Experimental Toxicology · doi:10.1177/0960327119839160 · Cited by 19 · see citing works
Nam, S. T., Kim, D. H., Lee, M. B., Nam, H. J., Kang, J. K., Park, M. J., Lee, I. H., Seok, H., Lee, D. G., Hwang, J. S., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.06.031 · Cited by 17 · see citing works
., M. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660188 · Cited by 17 · see citing works
Aldayel, T. S., El-Hak, H. N. G., Nafie, M. S., Saad, R., Abdelrazek, H. M. A., & Kilany, O. E. (2023) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-04279-z · Cited by 16 · see citing works
Docking of Natural Products against Neurodegenerative Diseases: General Concepts
Ribeiro, F. F., Mendonça, F. J. B., Ghasemi, J. B., Ishiki, H. M., Scotti, L., & Scotti, L. (2018) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207321666180313130314 · Cited by 16 · see citing works
Hannan, M. A., Haque, M. N., Munni, Y. A., Oktaviani, D. F., Timalsina, B., Dash, R., Afrin, T., & Moon, I. S. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.104957 · Cited by 15 · see citing works
Morissette, M., Litim, N., & Paolo, T. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809593-5.00002-1 · Cited by 14 · see citing works
Zhou, T., Zhuang, J., Wang, Z., Zhou, Y., Li, W., Wang, Z., & Zhu, Z. (2019) · Neuroreport · doi:10.1097/wnr.0000000000001202 · Cited by 14 · see citing works
Cutaneous mucinosis associated with thyroid dysfunction.
Schaeffer, D., Bruce, S., & Rosén, T. (1983) · PubMed · Cited by 14 · see citing works
Verma, H., Kaur, S., Kaur, S., Gangwar, P., Dhiman, M., & Mantha, A. K. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04053-3 · Cited by 11 · see citing works
Nine Steps to Discover New Medicines from Traditional Sources: The Example of Persian Medicine
Mozaffarpur, S. A., Naseri, M., Kamalinejad, M., Shams, M. A., Memariani, Z., Moeini, R., Gorji, N., Farahani, A. M., & Shirafkan, H. (2020) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2019.0377 · Cited by 11 · see citing works
Yang, F., Zhou, L., Song, J., WangJinMei, A., Yang, Y., Tang, Z.-W., & Huang, Q. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00243 · Cited by 11 · see citing works
Pirolla, N. F. F., Batista, V. S., Viegas, F. P. D., Gontijo, V. S., McCarthy, C. R., Viegas, C., & Nascimento-Júnior, N. M. (2020) · Current Drug Targets · doi:10.2174/1389450121999200819144544 · Cited by 11 · see citing works
Self-citationEffect of Lycoris chejuensis and Its Active Components on Experimental Models of Alzheimer’s Disease
Kim, J., Park, Y., Chun, Y. S., Cha, J. W., Kwon, H. C., Oh, M. S., Chung, S., & Yang, H. O. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b00889 · Cited by 11 · see citing works
Dehydroabietylamine derivatives as multifunctional agents for the treatment of Alzheimer's disease
Cao, Y., Wang, L., Lin, Z., Liang, F., Pei, Z., Xu, J., & Gu, Q. (2014) · MedChemComm · doi:10.1039/c4md00305e · Cited by 10 · see citing works
Pharmacognostical Sources of Popular Medicine To Treat Alzheimer’s Disease
Kalász, H., Ojha, S. K., Tekes, K., Szőke, É., Rajesh, M., Fahim, M. F. M., Adeghate, E. A., & Adem, A. (2018) · The Open Medicinal Chemistry Journal · doi:10.2174/1874104501812010023 · Cited by 10 · see citing works
Chun, Y. S., Zhang, L., Li, H., Park, Y., Chung, S., & Yang, H. O. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1023-y · Cited by 10 · see citing works
Ortiz, C. J. C., Silva, M. D. F., Gontijo, V. S., Viegas, F. P. D., Dias, K. S. T., & Viegas, C. (2018) · Methods in pharmacology and toxicology · doi:10.1007/7653_2018_2 · Cited by 9 · see citing works
Self-citationGoyal, S., Arora, J., & Ramawat, K. G. (2014) · Sustainable development and biodiversity · doi:10.1007/978-3-319-09381-9_11 · Cited by 9 · see citing works
Centella asiatica (Gotu kola) leaves
Thakurdesai, P. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820593-8.00021-5 · Cited by 8 · see citing works
Franco, G. R. R., & Viegas, C. (2017) · Revista Virtual de Química · doi:10.21577/1984-6835.20170103 · Cited by 7 · see citing works
Self-citationNanotechnology Based Delivery Systems of Drugs Currently Used to Treat Alzheimer’s Disease
Choubdar, N., & Avizheh, S. (2019) · Nanoscience & Nanotechnology-Asia · doi:10.2174/2210681209666190228143636 · Cited by 7 · see citing works
Hegde, M. (2014) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.129168 · Cited by 6 · see citing works
“[3] However, the principle bioactive compound (s) in these plant products and/or molecular mechanisms behind their curative/preventive effects are very poorly understood, which is a roadblock to convince the more educated urban population about their benefits and to exploit these for the discovery…”
Neuropharmacological and Cognitive Effects of Celastrus paniculatus – A Comprehensive Review
Bhagya, V. R., & Jaideep, S. (2020) · International Journal of Pharmaceutical Sciences Review and Research · doi:10.47583/ijpsrr.2020.v65i01.013 · Cited by 6 · see citing works
Enogieru, A. B., & Inegbedion, G. O. (2022) · The Journal of Phytopharmacology · doi:10.31254/phyto.2022.11212 · Cited by 6 · see citing works
Maurya, H., Arya, R. K. K., Belwal, T., Rana, M. D., & Kumar, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819212-2.00036-0 · Cited by 6 · see citing works
Proposed remedies for some developmental disorders
Ibrahim, K. S., & El-Sayed, E. M. (2012) · Toxicology and Industrial Health · doi:10.1177/0748233711433937 · Cited by 6 · see citing works
Dey, A., Nanda, B., Nandy, S., Mukherjee, A., & Pandey, D. K. (2020) · Studies in natural products chemistry · doi:10.1016/b978-0-12-819483-6.00002-3 · Cited by 6 · see citing works
Khodadadi, H., Jahromi, G. P., Zaeinalifard, G., Fasihi‐Ramandi, M., Esmaeili, M. A., & Shahriary, A. (2020) · Neurophysiology · doi:10.1007/s11062-020-09861-6 · Cited by 6 · see citing works
Innate antiviral immunity of human PBLs and immunoregulatory activity of EGb 761
Sochocka, M., Taboł, A., Sobczyński, M., Zaczyńska, E., Czarny, A., & Leszek, J. (2013) · Open Life Sciences · doi:10.2478/s11535-013-0278-6 · Cited by 6 · see citing works
Lemieszewska, M., Polanowski, A., Wilusz, T., Sokołowska, A., Zambrowicz, A., Mikołajewicz, K., Macała, J., Rymaszewska, J., & Zabłocka, A. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/3760124 · Cited by 6 · see citing works
Quinazoline-2,4(1H,3H)-dione modulates STAT3 and FOXO3a signaling in HepG2 cells
Manoharan, S., Murugesan, K., Gunasekaran, S., Vedagiri, H., & Perumal, E. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108304 · Cited by 5 · see citing works
Indian Traditional Herbs and Alzheimer’s Disease: Integrating Ethnobotany and Phytotherapy
Malik, J., & Choudhary, S. (2021) · Springer eBooks · doi:10.1007/978-981-15-8127-4_50 · Cited by 5 · see citing works
CADD Studies Applied to Secondary Metabolites in the Anticancer Drug Research
Scotti, L., Yarla, N. S., Mendonça, F. J. B., Barbosa‐Filho, J. M., da Silva, M. S., Tavares, J. F., & Scotti, L. (2018) · Springer eBooks · doi:10.1007/978-981-10-8417-1_9 · Cited by 5 · see citing works
Potential Treatment Strategies of Dementia With Ayurvedic Medicines
Farooqui, A. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816347-4.00009-x · Cited by 4 · see citing works
Ozor, I. I., Agwag, Z. N., Finbarrs-Bello, E., Ozioko, O. M., Ozioko, U. S., & Iruka, N. C. (2020) · International Journal of Neurologic Physical Therapy · doi:10.11648/j.ijnpt.20200602.12 · Cited by 4 · see citing works
- Authors
- Divino da Rocha, M., Pereira Dias Viegas, F., Cristina Campos, H., Carolina Nicastro, P., Calve Fossaluzza, P., Alberto Manssour Fraga, C., J. Barreiro, E., & Viegas, C.
- Venue
- CNS & Neurological Disorders - Drug Targets
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2011-03-01
- Volume
- 10
- Issue
- 2
- Pages
- 251-270
- ISSN
- 1568-007X (ISSN-L)
- 1871-5273
- OpenAlex
- W2146833115
- Cited by
- 126
- References
- 294
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 5 · 2023: 7 · 2022: 5 · 2021: 11 · 2020: 18 · 2019: 7 · 2018: 13 · 2017: 6 · 2016: 9 · 2015: 8 · 2014: 12 · 2013: 8 · 2012: 10
- FWCI
- 6.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- CNS & Neurological Disorders - Drug Targets (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
- Health Sciences › Medicine › Pharmacology › Cholinesterase and Neurodegenerative Diseases
- Keywords
- Alzheimer's disease, natural products, phytochemicals, neuroprotection, amyloid plaques, amyloid-beta, tau protein, neurofibrillary tangles, neuroinflammation, secondary metabolites, drug discovery, ginseng, Salvia miltiorrhiza, turmeric, Ginkgo biloba, Huperzia serrata, Centella asiatica, Celastrus paniculatus, Magnolia officinalis, Polygala tenuifolia, Picrorhiza kurroa, cognitive impairment, mood and anxiety
- MeSH terms
- Alzheimer Disease, Biological Products, Central Nervous System, Humans, Neuroprotective Agents, Neurodegenerative Diseases, Drug Discovery, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review